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Introduction / objectives
The emergence of Acinetobacter baumannii as an epide-
miologically significant nosocomial agent based on its
epidemiology, antibiogram patterns and clinical correla-
tion was explored in a 25 month study at a tertiary care
hospital in India.
Methods
The Acinetobacter baumannii isolates over a twenty-five
month period (Dec’08-Dec’10) were studied retrospec-
tively for their antibiotic patterns, pathogenic stautus
and epidemiology with special reference to nosocomial
acquisition.
Setting
Superspeciality Tertiary care Indian hospital.
Results
A. baumannii were isolated in 354 samples out of 3036
gram negative isolates (11.6% prevalence) from the
entire hospital in the 25 month period. Maximum iso-
lates were from respiratory secretions (59.8%) followed
by blood (18.6%). Prevalence of A. baumannii rose to
29.5% (269 out of 909 gram negatives isolates) in ICU.
The nosocomial status of A. baumannii was revealed in
its contribution to 39.3% VAP, 38.7% CA-BSI, 12.6% SSI
and 16.9% CA-UTI. Overall resistance of A. baumannii
for carbapenems was 89% from all hospital isolates. ICU
isolates showed higher resistance (92.9%) as compared
to IPD (83.8%) and OPD (47.0%).
Conclusion
A. baumannii is mainly an ICU bug, showing 75.9% pre-
valence (269 isolates out of 354). Overuse of carbape-
nems in the ICU setting probably led to selection
pressure and high level resistance of Acinetobacter to
them. Hence implementation of antibiotic policy for
judicious use of antibiotics should be stressed on. Also,
one must prevent the nosocomial spread of Acinetobac-
ter by appropriate infection control measures.
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